483
NEURELECNEURELEC – FDA 483, Jun 2, 2022
Record Details
An FDA inspection of Oticon Medical, a manufacturer of Cochlear Implant devices, revealed significant deficiencies in its quality system. The firm failed to adequately establish procedures for complaint handling, including timely processing, documentation, and Medical Device Report (MDR) reportability evaluations. Additionally, corrective and preventive action activities, particularly investigations into device failures leading to recalls, were not properly documented.
View Company Profile
ID · 9e5c4a1f-ba0c-4c94-996d-bf9287452b54
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.